Meridian Bioscience Receives Re-Authorization from FDA for its Revogene® SARS-CoV-2 Molecular Assay July 29, 2022 Read More
Meridian Bioscience, Inc. Enters into Agreement to Be Acquired by SD Biosensor and SJL Partners in $1.53 Billion All-Cash Transaction July 8, 2022 Read More
Meridian Bioscience Announces Preliminary Results for Fiscal 2022 Third Quarter July 7, 2022 Read More
Meridian Launches New qPCR Master Mixes for Stool Samples to Accelerate Development of Molecular Assays June 20, 2022 Read More
Meridian Bioscience Launches Lyo-Ready qPCR Inhibitor Tolerant Blood-Specific Master Mixes for DNA & RNA Direct Detection May 29, 2022 Read More
Meridian Bioscience responds to the Monkeypox Outbreak with its Inhibitor-Tolerant qPCR Master Mixes for the Development of Molecular Tests May 26, 2022 Read More
Meridian Bioscience to Participate in the 2022 H.C. Wainwright Global Investment Conference May 23, 2022 Read More
Meridian Bioscience Launches Lyo-Ready Saliva-Specific Isothermal Amplification Master Mixes for Direct Detection of DNA & RNA in Point of Care Diagnostic Assays May 17, 2022 Read More
MERIDIAN BIOSCIENCE REPORTS RECORD SECOND QUARTER FISCAL 2022 OPERATING RESULTS May 6, 2022 Read More
